Cvi Holdings, LLC 9 Meters Biopharma, Inc. Transaction History

Cvi Holdings, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 11, 2021	SELL	$1.04 - $1.5 $2.22 Million - $3.2 Million	-2,134,460 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$0.84 - $2.16 $1.79 Million - $4.61 Million	2,134,460 New	2,134,460 $2.5 Million

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Cvi Holdings, LLC with notifications on news.